Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lives on the line: sex work in sub-Saharan Africa.

Lancet (London, England)·2015
Same author

Country in Focus: Diabetes and obesity in South Africa.

The lancet. Diabetes & endocrinology·2014
Same author

Big pharma in the dock over patent law plot in South Africa.

Lancet (London, England)·2014
Same author

MIM conference focuses on malaria elimination.

Lancet (London, England)·2013
Same author

Profile: SATVI--a leading light in tuberculosis vaccine research.

Lancet (London, England)·2013
Same author

Southern African declaration targets TB in mining sector.

Lancet (London, England)·2012

相关实验视频

Updated: Jul 10, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

南非总统暗示扩大艾滋病毒药物试点计划.

Adele Baleta

    Lancet (London, England)
    |February 28, 2002
    PubMed
    概括

    No abstract available in PubMed .

    更多相关视频

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    相关实验视频

    Last Updated: Jul 10, 2026

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
    23:56

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

    Published on: October 31, 2010

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018